Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)An Early Phase Study of NEI-01 in Patients With Solid Tumors or Acute Myeloid Leukemia
Phase 1
Active, not recruiting
- Conditions
- Relapsed AMLAdvanced Solid TumorRefractory AML
- Interventions
- First Posted Date
- 2022-02-07
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- New Epsilon Innovation Limited
- Target Recruit Count
- 24
- Registration Number
- NCT05226468
- Locations
- 🇭🇰
The University of Hong Kong Phase I Clinical Trials Centre, Hong Kong, Hong Kong
News
No news found